Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice

@article{Niu2008LossOA,
  title={Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice},
  author={Ming-Jia Niu and Jin-Kui Yang and Shan-Shan Lin and Xiu-Juan Ji and Li-min Guo},
  journal={Endocrine},
  year={2008},
  volume={34},
  pages={56-61}
}
This study aimed to investigate the role of angiotensin-converting enzyme 2 (ACE2) in regulating glucose homeostasis. Immunohistochemistry was used to investigate ACE2 expression in the pancreas. Glucose tolerance test, insulin secretion test, and insulin tolerance test were performed in age-matched male ACE2 knockout (KO) and wild-type (WT) mice. We found that ACE2 was positively expressed in the pancreas. Male ACE2 KO mice displayed a selective decrease in first-phase insulin secretion in… Expand
High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice.
TLDR
It is demonstrated that HFD feeding increases RAS activity and mediates glycemic dysregulation likely through loss of ACE2 present outside the islets but independently of changes in islet ACE2. Expand
Angiotensin I–Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice
TLDR
Findings identify ACE2 as a novel target for the prevention of β-cell dysfunction and apoptosis occurring in type 2 diabetes. Expand
ACE2 deficiency shifts energy metabolism towards glucose utilization.
TLDR
ACE2-knockout mice showed a β-cell defect associated with low insulin and collectrin levels and reduced compensatory hypertrophy in response to a HFD, which were not reversed by perindopril, suggesting that these were dependent on Angiotensin II (Ang II). Expand
Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
TLDR
The data suggest that decreased pancreatic ACE2 is a link between overactive RAS and impaired glycemia in T2DM, and maintenance of a normal endogenous ACE2 compensatory activity in the pancreas appears critical to avoid β-cell dysfunction, supporting a therapeutic potential for ACE2 in controlling diabetes resulting from an over active RAS. Expand
The ACE2/Ang-(1–7)/Mas axis can inhibit hepatic insulin resistance
TLDR
This is the first time documented that the ACE2/Ang-(1-7)/Mas axis can ameliorate insulin resistance in the liver and may serve as a new diabetes target. Expand
ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.
TLDR
A critical role is demonstrated for endogenous ACE2 in the adaptiveβ-cell hyperinsulinemic response to HF feeding through regulation of β-cell proliferation and growth in islet dysfunction and T2D. Expand
Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells.
TLDR
It is found that ACE2 over-expression restored glucose-stimulated insulin secretion (GSIS) and mitochondrial membrane potential (MMP) in the presence of H2O2 in INS-1 cells and restored impaired mitochondrial oxidation. Expand
ACE2 Pathway Regulates Thermogenesis and Energy Metabolism
TLDR
It is found that ACE2 is highly expressed in brown adipose tissue (BAT) and that cold stimulation increases ACE2 and Ang-(1-7) levels in BAT and serum and proposed that adaptive thermogenesis requires regulation of ACE2 pathway. Expand
Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
TLDR
It is shown that deletion ofACE2 aggravates liver steatosis, which is correlated with the increased expression of hepatic lipogenic genes and the decreased expression of fatty acid oxidation-related genes in the liver of ACE2 knockout (ACE2−/y) mice, and the results indicated that Ang-(1–7)/ACE2/Mas axis may reduce liver lipid accumulation partly by regulating lipid-metabolizing genes through ATP/P2 receptor/CaM signaling pathway. Expand
Tissue-Specific Pattern of Angiotensin-Converting Enzyme 2 Expression in Rat Pancreas
  • H. Fang, J. Yang
  • Biology, Medicine
  • The Journal of international medical research
  • 2010
TLDR
The expression of ACE2 in rat pancreatic exocrine and endocrine tissue is investigated to suggest that ACE2 might play an important role in glucose homeostasis. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 31 REFERENCES
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
TLDR
The identification of ACE2 in the kidney, its modulation in diabetes, and the recent description that this enzyme plays a biological role in the generation and degradation of various angiotensin peptides provides a rationale to further explore the role of this enzyme in various pathophysiological states including diabetic complications. Expand
Angiotensin-converting enzyme II in the heart and the kidney.
TLDR
ACE2 not only controls angiotensin II levels but functions as a protease on additional molecular targets that could contribute to the observed in vivo phenotypes of ACE2 mutant mice, suggesting that ACE2 seems to be a molecule that has protective roles in heart and kidney. Expand
Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis
TLDR
It is concluded that deletion of the ACE2 gene leads to the development of angiotensin II-dependent glomerular injury in male mice, with ACE2 likely to be an important therapeutic target in kidney disease. Expand
Angiotensin-Converting Enzyme 2 (ACE2) and ACE Activities Display Tissue-Specific Sensitivity to Undernutrition-Programmed Hypertension in the Adult Rat
TLDR
It is shown that ACE2 and ACE are coexpressed in numerous rat tissues and that their increased activity in the lung of FR30 rats may participate in hypertension programming, suggesting tissue-specific sensitivity to programming. Expand
Angiotensin II Type 1 Receptor Blockade Improves β-Cell Function and Glucose Tolerance in a Mouse Model of Type 2 Diabetes
TLDR
The present findings indicate that AT1R antagonism improves β-cell function and glucose tolerance in young type 2 diabetic mice and plays a role in the pathogenesis of human type 2 diabetes. Expand
Angiotensin-converting enzyme 2 is an essential regulator of heart function
TLDR
These genetic data for ACE2 show that it is an essential regulator of heart function in vivo and targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Expand
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.
TLDR
Improvements in structural parameters were also associated with functional improvements in first-phase insulin secretion and provide a possible mechanism for the reduced incidence of new-onset diabetes that has been observed in clinical trials of RAS blockade. Expand
Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.
TLDR
The finding that chronic ACE2 inhibition increases UAE suggests that ACE2, likely by modulating the levels of glomerular angiotensin II via its degradation, may be a target for therapeutic interventions that aim to reduce albuminuria and glomersular injury. Expand
Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets
TLDR
The existence of an islet angiotensin-generating system of potential importance in the physiological regulation of glucose-induced insulin secretion, thus diabetes mellitus is indicated. Expand
Loss of ARNT/HIF1β Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes
TLDR
Using oligonucleotide microarrays and real-time PCR of pancreatic islets isolated from humans with type 2 diabetes versus normal glucose-tolerant controls and beta cell-specific ARNT knockout mice, data suggest an important role for decreased ARNT and altered gene expression in the impaired islet function of human type 1 diabetes. Expand
...
1
2
3
4
...